SEC Form 4 · accession 0001140361-16-075767
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael F Demane
Director
Period of report
Aug 9, 2016
Accepted (ET)
Aug 11, 2016 · 11:03 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 9, 2016 | S | 6,667 | $89.00 | D | 499,252 | D | |
| Common Stock | Aug 9, 2016 | S | 6,666 | $94.00 | D | 492,586 | D | |
| Common StockF2 | Aug 9, 2016 | S | 3,333 | $89.00 | D | 79,222 | I | See footnote |
| Common StockF2 | Aug 9, 2016 | S | 3,334 | $94.00 | D | 75,888 | I | See footnote |
| Common StockF3 | Aug 9, 2016 | S | 3,333 | $89.00 | D | 10,923 | I | See footnote |
| Common StockF3 | Aug 9, 2016 | S | 3,334 | $94.00 | D | 7,589 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- F2Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
- F3Shares held by The Michael F. DeMane 2013 Retained Annuity Trust.